Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction

Aims. We investigate the effect of glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors on long-term outcomes following percutaneous coronary intervention (PCI) after non-ST elevation myocardial infarction (NSTEMI). Meta-analyses indicate that these agents are associated with improved short-term outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, J. P., Jones, D. A., Gallagher, S., Rathod, K., Antoniou, S., Wright, P., Knight, C., Mathur, A., Weerackody, R., Wragg, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034401/
https://www.ncbi.nlm.nih.gov/pubmed/24895595
http://dx.doi.org/10.1155/2014/643981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034401/
https://www.ncbi.nlm.nih.gov/pubmed/24895595
http://dx.doi.org/10.1155/2014/643981

Ejemplares similares